5 Best Low-Priced Growth Stocks To Buy

In this article, we will take a look at the 5 best low-priced growth stocks to buy. To see more such companies, go directly to 12 Best Low-Priced Growth Stocks To Buy.

5. ADMA Biologics, Inc. (NASDAQ:ADMA)

Number of Hedge Fund Holders: 21

ADMA Biologics, Inc. (NASDAQ:ADMA) is a biotech company whose shares have shown a remarkable performance over the past 12 months, gaining about 80% in value. In March, ADMA Biologics, Inc. (NASDAQ:ADMA) posted its quarterly results. GAAP EPS in the period came in at -$0.06, beating estimates by $0.01. Revenue in the quarter jumped about 90% year over year to reach $49.95 million, beating estimates by $1.88 million. ADMA Biologics, Inc. (NASDAQ:ADMA) also said it expects to generate positive EBITDA by the second half of 2023.

At the conclusion of the fourth quarter of 2022, 21 hedge funds in Insider Monkey’s database of 943 hedge funds had stakes in ADMA Biologics, Inc. (NASDAQ:ADMA). The biggest hedge fund stakeholder of ADMA Biologics, Inc. (NASDAQ:ADMA) was Joseph Edelman’s Perceptive Advisors which had a $46 million stake in the company.